Source-based drug interaction reference · English
Drug interactions in English: source-based medicine pair records — Page 213
How to use this directory
Each record describes a documented medicine pair and links to its source information. Coverage is selective. Missing records do not establish safe use, and these pages do not replace individual review by a qualified healthcare professional.
These records are for information and research. Do not start, stop or change medicines based on a web page. Product formulations, licensed uses and advice can differ by country.
Efavirenz and Methadone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Oxycodone: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Phenytoin sodium (Epdantoin 100 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Pravastatin sodium (Lipostat 20 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Praziquantel (Prazikuantel): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Raltegravir: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Rifabutin: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Rifampicin (Rifcap 300 mg Kapsül): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Rilpivirine: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Rimegepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Sertraline hydrochloride (Lustral 100 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Sertraline hydrochloride (Selectra 50 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Sertraline hydrochloride (Serlift 50 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Simvastatin (Lipex 20 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Simvastatin (Zocor 20 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Sofosbuvir / velpatasvir (Epclusa 400 mg/100 mg Film Kaplı Tablet): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Tacrolimus (Prograf 1 mg Sert Jelatin Kapsül): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Verapamil hydrochloride (İsoptin 80 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Verapamil hydrochloride (İsoptin 120 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Verapamil hydrochloride (İsoptin SR 240 mg): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Voclosporin: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Vonoprazan interaction
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Voriconazole (Voriconazole (Vorikonazol)): interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 37.5 mg and Ketoprofen interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 37.5 mg and Metaxalone interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 37.5 mg and Piroxicam interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 37.5 mg and Tapentadol interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 37.5 mg and Vilazodone interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 75 mg and Ketoprofen interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 75 mg and Metaxalone interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 75 mg and Piroxicam interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 75 mg and Tapentadol interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 75 mg and Vilazodone interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 150 mg and Ketoprofen interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 150 mg and Metaxalone interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 150 mg and Piroxicam interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 150 mg and Tapentadol interaction
Source-based drug interaction information. Detailed information is available with page access.
Efexor XR 150 mg and Vilazodone interaction
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Alirocumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Donanemab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Dupilumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Eptinezumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Erenumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Etrasimod: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Evolocumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Guselkumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Lebrikizumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Lecanemab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.
Efgartigimod alfa and Nemolizumab: Interaction Information
Source-based drug interaction information. Detailed information is available with page access.